| pubmed-article:7755609 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7755609 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:7755609 | lifeskim:mentions | umls-concept:C0007806 | lld:lifeskim |
| pubmed-article:7755609 | lifeskim:mentions | umls-concept:C0033684 | lld:lifeskim |
| pubmed-article:7755609 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:7755609 | lifeskim:mentions | umls-concept:C1707520 | lld:lifeskim |
| pubmed-article:7755609 | lifeskim:mentions | umls-concept:C1709634 | lld:lifeskim |
| pubmed-article:7755609 | lifeskim:mentions | umls-concept:C2353566 | lld:lifeskim |
| pubmed-article:7755609 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:7755609 | pubmed:dateCreated | 1995-6-21 | lld:pubmed |
| pubmed-article:7755609 | pubmed:abstractText | We investigated the levels of amyloid precursor protein (APP) and beta-amyloid peptide (A beta) in the cerebrospinal fluid (CSF) from 110 individuals ranging in age from newborn to 82-years old to analyze their regulation with age. These samples were segregated into two groups; one group contained CSF samples from patients with diagnosed CNS abnormalities and the second group contained CSF samples from patients with no known CNS disorders. The presence of APP and A beta was detected in all ages and from both CSF groups. No significant difference in the average level of A beta or APP was noted from either group with a change in age. However, a positive correlation was found to exist between levels of APP and A beta in individuals 25 years and older, suggesting that APP and A beta processing in the CSF is developmentally regulated. This observation was observed for both CSF groups. | lld:pubmed |
| pubmed-article:7755609 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7755609 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7755609 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7755609 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7755609 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7755609 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7755609 | pubmed:month | May | lld:pubmed |
| pubmed-article:7755609 | pubmed:issn | 0006-291X | lld:pubmed |
| pubmed-article:7755609 | pubmed:author | pubmed-author:CHUT MTM | lld:pubmed |
| pubmed-article:7755609 | pubmed:author | pubmed-author:CarrollR TRT | lld:pubmed |
| pubmed-article:7755609 | pubmed:author | pubmed-author:EmmerlingM... | lld:pubmed |
| pubmed-article:7755609 | pubmed:author | pubmed-author:LustM RMR | lld:pubmed |
| pubmed-article:7755609 | pubmed:author | pubmed-author:DoyleP DPD | lld:pubmed |
| pubmed-article:7755609 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7755609 | pubmed:day | 16 | lld:pubmed |
| pubmed-article:7755609 | pubmed:volume | 210 | lld:pubmed |
| pubmed-article:7755609 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7755609 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7755609 | pubmed:pagination | 345-9 | lld:pubmed |
| pubmed-article:7755609 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:7755609 | pubmed:meshHeading | pubmed-meshheading:7755609-... | lld:pubmed |
| pubmed-article:7755609 | pubmed:meshHeading | pubmed-meshheading:7755609-... | lld:pubmed |
| pubmed-article:7755609 | pubmed:meshHeading | pubmed-meshheading:7755609-... | lld:pubmed |
| pubmed-article:7755609 | pubmed:meshHeading | pubmed-meshheading:7755609-... | lld:pubmed |
| pubmed-article:7755609 | pubmed:meshHeading | pubmed-meshheading:7755609-... | lld:pubmed |
| pubmed-article:7755609 | pubmed:meshHeading | pubmed-meshheading:7755609-... | lld:pubmed |
| pubmed-article:7755609 | pubmed:meshHeading | pubmed-meshheading:7755609-... | lld:pubmed |
| pubmed-article:7755609 | pubmed:meshHeading | pubmed-meshheading:7755609-... | lld:pubmed |
| pubmed-article:7755609 | pubmed:meshHeading | pubmed-meshheading:7755609-... | lld:pubmed |
| pubmed-article:7755609 | pubmed:meshHeading | pubmed-meshheading:7755609-... | lld:pubmed |
| pubmed-article:7755609 | pubmed:meshHeading | pubmed-meshheading:7755609-... | lld:pubmed |
| pubmed-article:7755609 | pubmed:meshHeading | pubmed-meshheading:7755609-... | lld:pubmed |
| pubmed-article:7755609 | pubmed:meshHeading | pubmed-meshheading:7755609-... | lld:pubmed |
| pubmed-article:7755609 | pubmed:meshHeading | pubmed-meshheading:7755609-... | lld:pubmed |
| pubmed-article:7755609 | pubmed:meshHeading | pubmed-meshheading:7755609-... | lld:pubmed |
| pubmed-article:7755609 | pubmed:meshHeading | pubmed-meshheading:7755609-... | lld:pubmed |
| pubmed-article:7755609 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7755609 | pubmed:articleTitle | An age-related correlation between levels of beta-amyloid precursor protein and beta-amyloid in human cerebrospinal fluid. | lld:pubmed |
| pubmed-article:7755609 | pubmed:affiliation | Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, Ann Arbor, Michigan 48106, USA. | lld:pubmed |
| pubmed-article:7755609 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7755609 | lld:pubmed |
